C12Y 305/04014
Deoxycytidine deaminase
Official title: Deoxycytidine deaminase (3.5.4.14)
C12Y305/04014 (Deoxycytidine deaminase) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 4
- Assignees
- 3
- Inventors
- 14
- Latest grant
- 3 Jul 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
By publication year.
Recent patents
- Apobec3a as an anti-tumor agent5 May 2016US 2016/0120962 A1Invectys
- Cellular apobec3 proteins and modulators thereof for regulating dna repair processes and treating proliferative diseases23 Apr 2015US 2015/0111836 A1
- Stable recombinant adenosine deaminase19 Feb 2009US 2009/0047271 A1Enzon Pharmaceuticals, Inc.
- Cytidine deaminase activators, deoxycytidine deaminase activators, Vif antagonists, and methods of screening for molecules thereof26 May 2005US 2005/0112555 A1
Most cited
By later US patents